NDC 50419-541-01
Kerendia 20 mg/1
finerenone · TABLET, FILM COATED
Kerendia (finerenone) is an oral tablet used to treat chronic kidney disease in patients with type 2 diabetes. It works by blocking mineralocorticoid receptors, which helps protect the kidneys from further damage.
Key Facts
- Brand Name
- Kerendia
- Generic Name
- finerenone
- NDC Code (Package)
50419-541-01- NDC Code (Product)
50419-541- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 20 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215341
- Drug Class
- Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
- Marketing Start
- 07/09/2021
Recall History
No Recall HistoryView Full Drug Page
Kerendia — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.